Remedent, Inc, through its subsidiaries, researches, designs, develops, manufactures, and distributes oral care and cosmetic dentistry products. It primarily provides professional veneers and teeth whitening products for professional and over-the-counter use. The company offers River8, a prefab veneer that enables the dentist to find the right combination of teeth for a patient with minor reshaping.
Read More…
Industry, Sector and Symbol
Industry Dental equipment & supplies
Sub-IndustryN/A
SectorMedical
Phone011-32-9241-5880
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$1.60 million
Profitability
Miscellaneous
Employees11
Next Earnings Date11/13/2019 (Estimated)
OptionableNot Optionable
Remedent (OTCMKTS:REMI) Frequently Asked Questions
What is Remedent's stock symbol?
Remedent trades on the OTCMKTS under the ticker symbol "REMI."
When is Remedent's next earnings date?
Has Remedent been receiving favorable news coverage?
News stories about REMI stock have trended somewhat positive recently, according to InfoTrie. The research firm scores the sentiment of media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Remedent earned a news sentiment score of 1.8 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the immediate future. View News Stories for Remedent.
Who are some of Remedent's key competitors?
What other stocks do shareholders of Remedent own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Remedent investors own include CoStar Group (CSGP), MKS Instruments (MKSI), Old Line Bancshares, Inc. (MD) (OLBK), Enterprise Products Partners (EPD), Kellogg (K), M&T Bank (MTB), Restoration Hardware (RH), AT&T (T), Taiwan Semiconductor Mfg. (TSM) and Visteon (VC).
Who are Remedent's key executives?
Remedent's management team includes the folowing people:
- Mr. Guy De Vreese, Chairman & CEO (Age 64)
- Mr. Philippe Van Acker, CFO, Chief Accounting Officer, Controller & Director (Age 54)
- Mr. Mark E. Sernatinger, Exec. Officer of United States Office
- Mr. Scott G. Juhl, Exec. Officer of United States Office
- Mr. Stacey J. Ammons, Exec. Officer of United States Office
How do I buy shares of Remedent?
Shares of REMI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Remedent's stock price today?
One share of REMI stock can currently be purchased for approximately $0.17.
How big of a company is Remedent?
What is Remedent's official website?
How can I contact Remedent?
Remedent's mailing address is BELGIUM ZUIDERLAAN 1-3 BUS 8, GHENT C9, 9000. The company can be reached via phone at 011-32-9241-5880.
MarketBeat Community Rating for Remedent (OTCMKTS REMI)
MarketBeat's community ratings are surveys of what our community members think about Remedent and other stocks. Vote "Outperform" if you believe REMI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe REMI will underperform the S&P 500 over the long term. You may vote once every thirty days.
